[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Winning Strategies in Molecular Diagnostics 2021: Sapplier Shares and Market Segment Forecasts--Integrating New Technology Planning with Business and Corporate Strategies--Technological Breakthroughs, Emerging Tests, Competitive Intelligence

September 2017 | 1050 pages | ID: WE19723AFC3EN
Venture Planning Group

US$ 24,500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
This new seven-country study from LeadingMarketResearchcontains 1,050 pages, 96 tables, and is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the molecular diagnostics market during the next five years.Highlights- Business and technological trends in seven major markets: France, Germany, Italy, Japan, Spain, UK, and US- Five-year test volume and sales forecasts- Market shares of leading competitors- Feature comparison of major analyzers- Profiles of market players and start-up firms developing innovative technologies and products- Specific product and business opportunities for instrument and consumable suppliers.RationaleThe molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods.In order to successfully capitalize on the opportunities presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years.Geographic Coverage- France- Germany- Italy- Japan- Spain- UK- USAWorldwide Market Overview- Laboratories performing DNA sequencing and molecular diagnostic testingby country and market segment.- Five-year test volume and sales projections by country.Market Segmentation Analysis- Sales and market shares of major suppliers of molecular diagnosticreagent kits and components.- Five-year test volume and sales forecasts for major applications, including:- Infectious Diseases- Forensic Testing- Cancer- Paternity Testing/HLA Typing- Genetic Diseases- Others- Five-year test volume and sales projections for over 30 NAT assays.- A comprehensive analysis of the sequencing market, by country and laboratory segment, including:- Industrial- Academic- Government- Commercial- Detailed market segmentation analysis, including review of the market dynamics, trends, structure, size, growth and major suppliers, by country.Product/Technology Review- Comparison of leading molecular diagnosticanalyzers from Abbott, Beckman Coulter, BD, Bio-Rad,Gen-Probe, Roche, Tecan and other suppliers.- Extensive review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods, including:- PCR- bDNA- SDA- NASBA- TMA- SSSR, and others- LCR- Worldwide listings of companies, universities and research centers developing new molecular- diagnostictechnologies and products.Competitive Assessments- Extensive strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new technologies/products in R&D.- Comprehensive listings of companies developing and marketing molecular diagnostics products, by test and application.Opportunities and Strategic Recommendations- Specific new product development opportunities with potentially significant market appeal during the next five years.- Design criteria for new products.- Alternative market penetration strategies.- Potential market entry barriers and risks.- Business planning issues and concerns.MethodologyThis report is based on a combination of primary and secondary information sources, including interviews with laboratory directors and executives of leading diagnostic companies and start-up firms developing innovative technologies and products in the U.S., five major European countries and Japan. In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as LeadingMarketResearchs proprietary data base was conducted.Contains 1,050 pages and 96 tables
INTRODUCTION

WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

A. DNA Sequencing
  1. Introduction
  2. Sequencing Methods
  3. Autoradiography
  4. The Human Genome Project
  5. Sequencing Automation
  6. Image Scanners
  7. Fluorescent Detection
  8. Gene Profiling
  9. Gene Expression
  10. Polymorphism Screening
  11. Protein Interaction Networks
B. DNA And RNA Probe Technology
  1. Basic Principles
  2. Probe Preparation
  3. The DNA Probe Test
    a. Sample Preparation
    b. Hybridization
    c. Separation
    d. Detection/Measurement
  4. Test Formats
    a. Filter Hybridization
    b. Southern Blot
    c. Northern Blot
    d. In Situ Hybridization
    e. Others
  5. Labeling Techniques
  6. Amplification Methods
    Polymerase Chain Reaction
    Temperature Cyclers
    PCR Variations
      Immuno-PCR
      QC-PCR
      DAP-PCR
    Strand Displacement Activation
    TMA
    Ligase Chain Reaction
    Branched DNA
    Hybridization Protection Assay
    Nucleic-Acid Sequence-Based Amplification
    Self-Sustained Sequence Replicase
    Others
    Ampliprobe
    CAR
    CAS
    CPT
    Dendritic Polymer Technology
    ISO-CR
    LAT
    Probe Networks
    RAMP
    Repair Chain Reaction
    Rolling Circles
    Sequence Independent Gene Amplification
    Sequence Initiation Reaction
    SISPA
    Solid Phase Amplification
C. Detection Technologies
  1. Radioactive Methods
    a. Overview
    b. Major Isotopes
    P-32
    S-35
    H-3
    I-125
  2. Non-Isotopic Methods
    a. Enzymatic Labels
    b. Chemical Labeling
    Indirect Chemical Labeling
    Direct Chemical Labeling
    c. Fluorescence
    d. Chemiluminescence
    e. Electrical Conductivity
D. Instrumentation Review
  1. Abbott LCx
  2. Beckman Coulter/Biomek FK
  3. Becton Dickinson SDA
  4. Bio-Rad GeneScope
  5. Gen-Probe Tigris
  6. Roche Cobas Amplicor 7. Tecan LS Series
E. Biochips: Genosensors, Microarrays, and Labs-on-the-Chip
Liquid Transportation and Mixing
Separation
Reaction
Detection
F. Pharmacogenomics
G. Major Applications
  1. Microbiology/Infectious Diseases
    a. Overview
    b. Major Infectious Diseases
      AIDS
      Structure and Composition
      Classification
      AIDS Origins
      Animal Lentivirus Systems
      Virus Receptors
      HIV Infections in Humans
    Pathogenesis and Pathology
      CD4T Lymphocytes and Memory Cells
      Monocytes and Macrophages
      Lymphoid Organs
      Neural Cells
      Viral Coinfections
    Clinical Findings
      Plasma Viral Load
      Pediatric AIDS
    Neurologic Disease
    Opportunistic Infections
    Cancer
      Immunity
    Virus Isolation
    Serology
    Viral Nucleic Acid/Antigen Detection
      Epidemiology
    Worldwide Spread of AIDS
    United States
    Routes of Transmission
    DNA Probes
    Overview
    Quantitative PCR
    In Situ PCR
    Needed Improvements
    Viral Load/Drug Resistance Testing
    Genotype and Phenotype Testing
    Blood Banking Considerations
      Adenovirus
    Background
    Diagnostic Tests
    Vaccines and Drugs
    Adeno-Associated Viruses (AAV)
      Anthrax/Bacillus Anthracis
    Background
    Diagnostic Tests
    Vaccines and Drugs
      Babesiosis
    Background
      BEA and Other Bartonella Diseases
    Background
    Diagnostic Tests
    Vaccines and Drugs
      Chagas Disease
    Background
      Campylobacter
    Background
    Diagnostic Tests
    Culture Identification
    Vaccines and Drugs
      Chlamydia
    Background
    Chlamydia psittaci
    Chlmaydia pneumoniae
    Chlamydia trachomatis
    Diagnostic Tests
    Vaccines and Drugs
      Creutzfeldt-Jakob’s Disease
    Background
    Blood Transmission
    Diagnostic Tests
    Major Commercial and Academic Players
    Bayer
    Disease Sciences/Bio Tec Global
    Imperial College School of Medicine
    Ortho-Clinical Diagnostics
    Pall
    ProMetic Life Sciences
    Proteome Sciences/Idexx
    Q-One Biotech
    Serono
    U.S. Agricultural Research Service
    Drugs
    Vaccines
      Cytomegalovirus
    Background
    Chorioretinitis
    Gastrointestinal
    Central Nervous System Disease
    Diagnostic Tests
    Vaccines and Drugs
      Ebola Virus
    Background
    Epidemiology
    Clinical Syndromes
    Diagnostic Tests
    Vaccines and Drugs
      EchoVirus
    Background
    Acute Aseptic Meningitisis
    Encephalitis
    Exanthems
    Respiratory Disease
    Myopericarditis
    Neonatal Infections
    Diagnostic Tests
    Vaccines and Drugs
      Encephalitis
    Background
    Diagnostic Tests
    Vaccines and Drugs
      Enteroviruses
    Background
    Diagnostic Tests
    Viral Isolation and Identification
    Antibody Tests
    Vaccines and Drugs
      Epstein-Barr Virus
    Background
    Diagnostic Tests
    Vaccines and Drugs
      Gonorrhea
    Background
    Diagnostic Tests
    Vaccines and Drugs
      Hepatitis
    Hepatitis A
    Hepatitis B
    Structure and Composition
    Replication
    Hepatitis C
    Hepatitis D (Delta)
    Hepatitis E
    Hepatitis G
    Hepatitis Infections Pathology
    Clinical Findings
    Laboratory Tests
    Hepatitis A
    Hepatitis B
    Hepatitis C
    Hepatitis D
    Hepatitis E
    Virus-Host Immune Reactions
    Epidemiology
    Hepatitis A
    Hepatitis B
    Hepatitis C
    Hepatitis D (Delta)
    Vaccines and Drugs
      Herpes Simplex Virus
    Background
    Diagnostic Tests
    Vaccines and Drugs
      Legionella
    Background
    Diagnostic Tests
    Vaccines and Drugs
      Lyme Disease
    Background
    Clinical Description
    Clinical Case Definition
    Laboratory Criteria for Diagnosis
    Case Classification
    Diagnostic Tests
    Vaccines and Drugs
      Malaria
      Mycoplasma
    Background
    Ureaplasma Urealyticum & Mycoplasma
Hominis
    Diagnostic Tests
    Vaccines and Drugs
      Papillomaviruses/HPV
    Background
    HPV in Cancer
    Cervical Neoplasm
    Diagnostic Tests
    Vaccines and Drugs
    Prevention
      Parvovirus B19
    Background
    Microbiology
    Epidemiology
    Clinical Syndromes
    Erythema Infectiosum (Slapped Cheek)
    Adult Polyarthropathy
    Transient Aplastic Crisis
    Transient Pancytopenia
    Red Cell Aplasia in Immunocompromised
    Perinatal Infections
    Diagnostic Test
    Vaccines and Drugs
      Pneumonia
    Background
    Diagnostic Tests
    Vaccines and Drugs
      Polyomaviruses
    Background
    Diagnostic Tests
    Vaccines and Drugs
      Salmonellosis
    Background
    Diagnostic Tests
    Vaccines and Drugs
      Shigellosis
    Background
    Diagnostic Tests
    Vaccines and Drugs
      Streptococci
    Background
    Diagnostic Tests
    Vaccines and Drugs
    Group A Streptococci
    Group B Streptococci
      Toxoplasmosis
    Background
    Diagnostic Tests
    Vaccines and Drugs
      Tuberculosis
    Background
    Diagnostic Tests
    Microscopic Characteristics
    Cultural Characteristics
    Skin Tests
    MDRTB
    Vaccines and Drugs
      West Nile Virus
    Background
    Clinical Syndromes
    Diagnostic Tests
    Vaccines and Drugs
      Yersinia
    Background
    Diagnostic Tests
    Vaccines and Drugs
    c. Antibiotic Susceptibility
  2. Cancer Testing
    a. Overview
    b. Major Cancer Types
      Prostate
      Lung
      Colon and Rectum
      Breast
      Skin
      Uterine
      Leukemia
      Oral
    c. Oncogenes
    Abl/abl-bcr
    AIB1
    BCL-2
    BRCA1
    CD44
    C-fos
    C-myb
    C-myc
    CYP17
    Erb-B
    HPC1
    N-myc
    P40
    P51
    P53
    PIK3CA
    PTI-1
    Ras
    Reg
    Sis
    Src
  3. Genetic Diseases
    a. Overview
    b. Nucleic Acid Amplification
    c. Chromosome Imaging
    d. Genomics Technologies
    e. Proteomics Technologies
    f. Current Pharmacogenomic Tests
    g. Future Pharmacogenomic Testing
    h. Major Diseases
      Achondroplasia
      Autosomal Dominant Polycystic Kidney Disease
      Cancer
      Cosmetogenomics
      Cystic Fibrosis
      Down's Syndrome
      Duchenne and Becker Muscular Dystrophy
      Factor V (Leiden)
      Factor IX Deficiency
      Fragile X Syndrome
      Heart Disease
      Hemochomatosis
      Hemophilia
      Huntington's Disease
      Maternal-Fetal Incompatibility
      Multiple Endocrine Neoplasia
      Phenylketonuria (PKU)
      Polycystic Kidney Disease (PKD)
      Prenatal Screening
      Retinitis Pigmentosa
      Retinoblastoma
      Sickle Cell Anemia
      Spinal Muscular Atrophy
      Vitamin B12 Metabolism
    i. Social Issues and Concerns
  4. Forensic Testing
    a. Overview
    b. Multilocus and Single Locus Probes
      Multilocus Probes
      Single Locus Probes
      PCR and RFLP
    c. The FBI
    d. DNA Profile Data Banks
      U.S.A.
      U.K.
    e. Judicial Implementation
    f. Major Crime Categories
    g. Factors Contributing to the DNA Probe Market Expansion
      Technology Availability
      Use of Hair as Evidence
    h. Wildlife Forensics
  5. Paternity Testing/HLA Typing
  6. Other Applications
    a. Disease Susceptibility Testing
    b. Cardiovascular Diseases
    c. Diabetes
    d. Alzheimer's Disease
    e. Periodontal Disease
    f. Plasma Purification
    g. Organ Transplantation
    h. Water Contamination
    i. Other
H. Competing/complementing Technologies
  1. Monoclonal Antibodies/Immunoassays
  2. RNA Probes
  3. Two-Dimensional Electrophoresis
  4. Flow Cytometry
I. Worldwide Market Overview
  1. Business Environment
  2. Market Structure
  3. Market Size and Growth

FRANCE

A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth And Major Suppliers’ Sales And Market Shares

GERMANY

A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth And Major Suppliers’ Sales And Market Shares

ITALY

A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth And Major Suppliers’ Sales And Market Shares

JAPAN

A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth And Major Suppliers’ Sales And Market Shares

SPAIN

A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth And Major Suppliers’ Sales And Market Shares

U.K.

A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth And Major Suppliers’ Sales And Market Shares

U.S.A.

A. Executive Summary
B. Business Environment
  1. Health Care Expenditures
  2. Cost Consciousness
  3. Reimbursement
  4. Industry Consolidation
  5. Managed Care
    a. PPO
    b. HMO
  6. Hospitals
  7. Admissions
  8. Length of Stay
  9. Industry Diversification
  10. Physician Demographics
  11. Population Aging
    a. Chronic Illness
    b. Disease Incidence
    c. Susceptibility to Iatrogenesis
    d. Multiple Illness Cases
  12. Laboratory Regulations
  13. FDA Reform
C. Market Structure
  1. Hospitals
  2. Commercial/Private Laboratories
  3. Blood Banks
D. Market Size, Growth and Major Suppliers’ Sales and Market Shares

MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES

A. Instrumentation
B. Reagent Kits and Test Systems/panels
C. Computers, Software and Automation
D. Auxiliary Products

DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS

ALTERNATIVE MARKET PENETRATION STRATEGIES

A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies For Decentralized Testing Markets
  1. Marketing Approaches
  2. Product Complexity
  3. Customer Preference
  4. Established Suppliers
  5. Emerging Suppliers
  6. Major Types Of Distributors
  7. Market Segmentation

POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge And Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

COMPETITIVE PROFILES

Abbott
Affymetrix
Agilent
Applied Gene Technologies
Arca3KDUPD
Beckman Coulter/Danaher
Becton Dickinson
Biokit
BioMerieux
Bio-Rad
Biotest
Cepheid
CellMark Forenciscs/LabCorp
Decode Genetics
Diadexus
Eiken
Elitech Group
Enzo
Exact Sciences
Fujirebio
Grifols
Hologic/Gen-Probe
Illumina
Kreatech/Leica
Li-Cor Biosciences
Monogram Biosciences
Myriad Genetics
Ortho-Clinical Diagnostics
Perkin Elmer/Caliper
Proteome Sciences
Qiagen
Roche
Scienion
Sequenom
Shimadzu
Siemens
Sierra Molecular
Takara Bio
Tecan Group
Thermo Fisher

APPENDIXES

Appendix I: Major Universities and Research Centers Developing Molecular Diagnostic Technology
Appendix II: Glossary of Terms
Appendix III: Currency Exchange Rates

LIST OF TABLES

Major Companies Developing or Marketing AIDS Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Adenovirus Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Campylobacter Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Chlamydia Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing CMV Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing EBV Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Gonorrhea Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Hepatitis Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Herpes Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Legionella Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Lyme Disease Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Mycoplasma Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Papilloma Virus Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Pneumonia Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Salmonella Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Shigella Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Streptococci Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Toxoplasmosis Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Tuberculosis Molecular Diagnostic And Other Direct Identification Tests
Oncogenes Potential Application in Cancer Diagnosis
Major Companies Developing or Marketing Cancer Molecular Diagnostic Tests
Major Companies Developing or Marketing Molecular Diagnostic Test For Genetic Diseases
Worldwide, Laboratories Performing DNA Sequencing By Country
Worldwide, Molecular Diagnostics Market Potential Laboratory Universe by Country
Worldwide, Molecular Diagnostic Test Volume Forecast By Country
Worldwide, Molecular Diagnostics Market Forecast by Country
Summary Table France, Molecular Diagnostic Test VolumeAnd Sales Forecast by Major Application
France, Laboratories Performing DNA Sequencing By Market Segment
France, Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
France, Molecular Diagnostic Test Volume Forecast By Major Application
France, Major Infectious Disease Molecular Diagnostics Test Volume Forecast
France, Infectious Disease Screening NAT Volume Forecast
France, Molecular Diagnostics Market Forecast By Major Application
France, Infectious Disease Screening NAT Reagent Market Forecast by Test
France, Molecular Diagnostics Market By Major Supplier
France, HIV/Hepatitis NAT Market Reagent Sales By Major Supplier
Summary Table Germany, Molecular Diagnostics Test VolumeAnd Sales Forecast by Major Application
Germany, Laboratories Performing DNA Sequencing by Market Segment
Germany, Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
Germany, Molecular Diagnostics Test Volume Forecast By Major Application
Germany, Major Infectious Disease Molecular Diagnostics Test Volume Forecast
Germany, Infectious Disease Screening NAT Volume Forecast
Germany, Molecular Diagnostics Market Forecast By Major Application
Germany, Infectious Disease Screening NAT Reagent Market Forecast by Test
Germany, Molecular Diagnostics Market by Major Supplier
Germany, HIV/Hepatitis NAT Market Reagent Sales by Major Supplier
Summary Table Italy, Molecular Diagnostics Test VolumeAnd Sales Forecast by Major Application
Italy, Laboratories Performing DNA Sequencing by Market Segment
Italy, Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
Italy, Molecular Diagnostics Test Volume Forecast By Major Application
Italy, Major Infectious Disease Molecular Diagnostics Test Volume Forecast
Italy, Infectious Disease Screening NAT Volume Forecast
Italy, Molecular Diagnostics Market Forecast By Major Application
Italy, Infectious Disease Screening Nat Reagent Market Forecast by Test
Italy, Molecular Diagnostics Market By Major Supplier
Italy, HIV/Hepatitis NAT Market By Major Supplier
Summary Table Japan, Molecular Diagnostics Test VolumeAnd Sales Forecast by Major Application
Japan, Laboratories Performing DNA Sequencing by Market Segment
Japan, Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
Japan, Molecular Diagnostics Test Volume Forecast By Major Application
Japan, Major Infectious Disease Molecular Diagnostics Test Volume Forecast
Japan, Infectious Disease Screening Nat Volume Forecast
Japan, Molecular Diagnostics Market Forecast By Major Application
Japan, Infectious Disease Screening Nat Reagent Market Forecast by Test
Japan, Molecular Diagnostics Market By Major Supplier
Japan, HIV/Hepatitis NAT Market Reagent Sales by Major Supplier
Summary Table Spain, Molecular Diagnostics Test VolumeAnd Sales Forecast by Major Application
Spain, Laboratories Performing DNA Sequencing by Market Segment
Spain, Molecular Diagnostics Market, Potential Laboratory Universe by Market Segment
Spain, Molecular Diagnostics Test Volume Forecast by Major Application
Spain, Major Infectious Disease Molecular Diagnostics Test Volume Forecast
Spain, Infectious Disease Screening Nat Volume Forecast
Spain, Molecular Diagnostics Market Forecast By Major Application
Spain, Infectious Disease Screening Nat Reagent Market Forecast by Test
Spain, Molecular Diagnostics Market By Major Supplier
Spain, HIV/Hepatitis NAT Market Reagent Sales by Major Supplier
Summary Table U.K., Molecular Diagnostics Test VolumeAnd Sales Forecast by Major Application
U.K., Laboratories Performing Dna Sequencing by Market Segment
U.K., Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
U.K., Molecular Diagnostics Test Volume Forecast By Major Application
U.K., Major Infectious Disease Molecular Diagnostics Test Volume Forecast
U.K., Infectious Disease Screening Nat Volume Forecast
U.K., Molecular Diagnostics Market Forecast By Major Application
U.K., Infectious Disease Screening NAT Reagent Market Forecast by Test
U.K., Molecular Diagnostics Market by Major Supplier
Summary Table U.S.A., Molecular Diagnostics Test VolumeAnd Sales Forecast by Major Application
U.S.A., Laboratories Performing DNA Sequencing by Market Segment
U.S.A., Molecular Diagnostics Market, Potential Laboratory Universe by Market Segment
U.S.A., Molecular Diagnostics Test Volume Forecast By Major Application
U.S.A., Major Infectious Disease Molecular Diagnostics Test Volume Forecast
U.S.A., Infectious Disease Screening Nat Volume by Test Forecast
U.S.A., Molecular Diagnostics Market Forecast By Major Application
U.S.A., Infectious Disease Screening Nat Reagent Market Forecast by Test
U.S.A., Molecular Diagnostics Market by Major Supplier
U.S.A., HIV/Hepatitis C NAT Market Reagent Sales By Major Supplier
U.S.A., West Nile Virus NAT Market Reagent Sales By Major Supplier


More Publications